Interestingly, the single nucleotide polymorphism (SNP) rs12435998 in SEL1L intron 3 has been reported to modify the age at diagnosis of Caucasian nonsmoker PDA patients, for which it was proposed as a diagnostic and prognostic marker [14]. This evidence concerns the gene SEL1L and Patent ductus arteriosus.